По вашему запросу найдено документов: 490

Страница 32 из 49

Клинические проявления и вопросы диагностики хронического цереброваскулярного заболевания (хронической ишемии головного мозга) на ранней (додементной) стадии
Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (pre-dementia) stage
Kulesh, A. A., Emelin, A. Yu., Bogolepova, A. N., Doronina, O. B., Zakharov, V. V., Kolokolov, O. V., Kotov, S. V., Korsunskaya, L. L., Kutlubaev, M. A., Laskov, V. B., Levin, O. S., Parfenov, V. A., Кулеш, А.А., Емелин, А.Ю., Боголепова, А.Н., Доронина, О.Б., Захаров, В.В., Колоколов, О.В., Котов, С.В., Корсунская, Л.Л., Кутлубаев, М.А., Ласков, В.Б., Левин, О.С., Парфенов, В.А. (2021)
diseases (primary headache, peripheral vestibular vertigo, and vestibular migraine). The diagnosis of DEP
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Beyer, J., Collette, L., Sauve, N., Daugaard, G., Feldman, D.R., Tandstad, T., Tryakin, A., Stahl, O., Gonzalez-Billalabeitia, E., De Giorgi, U., Culine, S., de Wit, R., Hansen, A.R., Bebek, M., Terbuch, A., Albany, C., Hentrich, M., Gietema, J.A., Negaard, H., Huddart, R.A., Lorch, A., Cafferty, F.H., Heng, D.Y.C., Sweeney, C.J., Winquist, E., Chovanec, M., Fankhauser, C., Stark, D., Grimison, P., Necchi, A., Tran, B., Heidenreich, A., Shamash, J., Sternberg, C.N., Vaughn, D.J., Duran, I., Bokemeyer, C., Patrikidou, A., Cathomas, R., Assele, S., Gillessen, S. (2021)
were included. Primary end points were progression-free survival (PFS) and overall survival (OS
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
Gillessen, S, Sauve, N, Collette, L, Daugaard, G, de Wit, R, Albany, C, Tryakin, A, Fizazi, K, Stahl, O, Gietema, JA, De Giorgi, U, Cafferty, F.H., Hansen, A.R., Tandstad, T, Huddart, R.A., Necchi, A, Sweeney, C.J., Garcia-Del-Muro, X, Heng, DYC, Lorch, A, Chovanec, M, Winquist, E, Grimison, P, Feldman, D.R., Terbuch, A, Hentrich, M, Bokemeyer, C, Negaard, H, Fankhauser, C, Shamash, J., Vaughn, DJ, Sternberg, CN, Heidenreich, A, Beyer, J (2021)
, and Australia. Clinical trial and registry data were included. Primary end points were progression-free survival
Опыт лечения BRCA-ассоциированного рака молочной железы. BRCA-история одной семьи
Experience in treating brca-associated breast cancer. The brca-history of a family
Sultanbaev, A.V., Menshikov, K.V., Nasretdinov, A.F., Izmailov, A.A., Musin, S.I., Menshikova, I.A., Chashchin, A.V., Sultanbaeva, N.I., Султанбаев, А. В., Меньшиков, К. В., Насретдинов, А. Ф., Измайлов, А. А., Мусин, Ш. И., Меньшикова, И. А., Чащин, А. В., Султанбаева, Н. И. (2021)
Breast cancer (BC) is the most common cancer and the primary cause of cancer death. About 5 to 10
Immunological Markers in Patients with Gastroenterological Manifestations During Different Periods of COVID-19
Sadretdinova, L.D., Gantseva, H.H., Itkulov, A.F., Tyurin, A.V. (2024)
was performed in phase I. The study was conducted. The primary objective was to evaluate clinical symptoms
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
Ruperto, N, Brunner, HI, Pacheco-Tena, C, Louw, I, Vega-Cornejo, G, Spindler, AJ, Kingsbury, DJ, Schmeling, H, Borzutzky, A, Cuttica, R, Inman, CJ, Malievskiy, V, Scott, C, Keltsev, V, Terreri, MT, Viola, DO, Xavier, RM, Fernandes, TAP, Velazquez, MDM, Henrickson, M, Clark, MB, Bensley, KA, Li, XM, Lo, KH, Leu, JH, Hsu, CH, Hsia, EC, Xu, ZH, Martini, A, Lovell, DJ, Group Authors:Pediat Rheumatology Collaborative (Pediat Rheumatology Collaborative), Paediat Rheumatology Int Trials Or (Paediat Rheumatology Int Trials Or) (2021)
through week 52 plus MTX weekly through week 28. The primary and major secondary endpoints were PK
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
-doublet chemotherapy). Patients were treated in 21-day or 28-day cycles. The primary endpoint was investigator
3D-конформная лучевая терапия при церебральных метастазах рака шейки матки
3D Conformal Radiotherapy in Cervical Metastasis to Brain
Р. К. Минязева, R. K. Minyazeva, Г. Ю. Батталова, G. Yu. Battalova, И. В. Сахаутдинова, I. V. Sakhautdinova, И. М. Таюпова, I. M. Tayupova, И. Р. Гилязова, I. R. Gilyazova (Креативная хирургия и онкология, №1, 2022)
Обзор предикторов развития рака печени
Predictors of Liver Cancer: a Review
А. И. Шерифова, A. I. Sherifova, А. М. Парсаданян, A. M. Parsadanyan (Креативная хирургия и онкология, №3, 2023)
primary liver cancer
СОВРЕМЕННЫЕ АСПЕКТЫ ЭПИДЕМИОЛОГИИ, ДИАГНОСТИКИ И ТЕРАПИИ КОЛОРЕКТАЛЬНОГО РАКА
MODERN ASPECTS OF EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER
Э. Т. Идиятуллина, E. T. Idiiatullina, В.Н. Павлов, V.N. Pavlov (Медицинский вестник Башкортостана, №4, 2017)

Страница 32 из 49

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год